Viewing Study NCT00814658

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:17 AM
Ignite Modification Date: 2026-01-22 @ 4:29 PM
Study NCT ID: NCT00814658
Status: COMPLETED
Last Update Posted: 2013-08-26
First Post: 2008-12-24
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: The Use of Galantamine (Reminyl ER) in Patients With MIXed Dementia: Effects on Cognition and Quality of Life
Sponsor: Janssen-Cilag Farmaceutica Ltda.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dementia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dementia View
None Mixed Dementia View
None Galantamine View
None Reminyl ER View
None Nimodipine View